Omalizumab usage in chronic urticaria and atopic dermatitis: data from South-East province of Turkey

INTRODUCTION: Omalizumab is a current treatment option for IgE-associated dermatoses, such as urticaria and atopic dermatitis. AIM: To evaluate the clinical and laboratory findings of patients with chronic urticaria and atopic dermatitis who received omalizumab. MATERIAL AND METHODS: This study was...

Full description

Saved in:
Bibliographic Details
Published in:Postepy Dermatol Alergol
Main Authors: Nazik, Hülya, Mülayim, Mehmet Kamil, Öztürk, Perihan
Format: Artigo
Language:Inglês
Published: Termedia Publishing House 2019
Subjects:
Original Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6986296/
https://ncbi.nlm.nih.gov/pubmed/31998003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2019.91424
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items